Spectrum of clinical manifestations of antiphospholipid antibodies in childhood and adolescence.
Nineteen children with circulating anticoagulants or anticardiolipin antibodies and negative or only weakly positive antinuclear factors were reviewed for their clinical manifestations. The relationship between these antibodies and the morbidity in the pediatric age group will be discussed.